SATOHAP- dl-camphor, l-menthol, methyl salicylate patch 
Sato Pharmaceutical Co., Ltd.

----------

Satohap Plaster

Active ingredients
dl-Camphor 0.5%
l-Menthol 0.4%
Methyl Salicylate 0.8%

Purpose
dl-Camphor    External analgesic
l-Menthol        External analgesic
Methyl Salicylate      External analgesic

Uses  temporary relieves minor aches and pains of muscles and joints associated with
■ simple backache    ■ arthritis    ■ strains    ■ bruises    ■ sprains

Warnings
For external use only

Do not use

■ on wounds or on damaged skin

When using this product

■ avoid contact with the eyes

■ do not bandage tightly

Stop use and ask a doctor if

■ condition worsens

■ symptoms persist for more than 7 days

■ symptoms clear up and occur again withn a few days


Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.


Directions
■ Strip off the polyethylene film and place adhesive pad over affected area.
■ Change pad 1 or 2 times a day
■ Not for children under 4 years.

Inactive ingredients
aluminum hydroxide gel, carbomer, carmellose sodium, edetate disodium, glycerin, malic acid, methacrylic acid and n-butyl acrylate copolymer, partially hydrolyzed polyvinyl alcohol, partially neutralized polyacrylate, PEG 60 hydrogenated castor oil, sorbitol, titanium dioxide, water.

-05 Carton

-02 Carton


SATOHAP 
dl-camphor, l-menthol, methyl salicylate patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49873-018
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) (CAMPHOR (SYNTHETIC) - UNII:5TJD82A1ET) CAMPHOR (SYNTHETIC)5 mg
LEVOMENTHOL (UNII: BZ1R15MTK7) (LEVOMENTHOL - UNII:BZ1R15MTK7) LEVOMENTHOL4 mg
METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE8 mg
Inactive Ingredients
Ingredient NameStrength
POLYVINYL ALCOHOL (UNII: 532B59J990)  
SORBITOL (UNII: 506T60A25R)  
GLYCERIN (UNII: PDC6A3C0OX)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
ALGELDRATE (UNII: 03J11K103C)  
MALIC ACID (UNII: 817L1N4CKP)  
WATER (UNII: 059QF0KO0R)  
POLYOXYL 60 HYDROGENATED CASTOR OIL (UNII: 02NG325BQG)  
ACRYLIC ACID/SODIUM ACRYLATE COPOLYMER (1:1; 600 MPA.S AT 0.2%) (UNII: M4PPW69Y4H)  
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
BUTYL ACRYLATE/METHACRYLIC ACID COPOLYMER (2% METHACRYLIC ACID) (UNII: Q984S31CYH)  
CARBOMER INTERPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 132584PQMO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49873-018-051 in 1 CARTON11/08/1989
15 in 1 POUCH; Type 0: Not a Combination Product
2NDC:49873-018-021 in 1 CARTON11/08/1989
25 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01711/08/1989
Labeler - Sato Pharmaceutical Co., Ltd. (690575642)
Establishment
NameAddressID/FEIBusiness Operations
Sato Pharmaceutical Co., Ltd.715699133label(49873-018) , pack(49873-018) , manufacture(49873-018)

Revised: 11/2023
Document Id: 09d87d9c-fe4d-fd02-e063-6394a90a56bd
Set id: df0e2b83-8f61-4ed8-bcc4-55e4ea782090
Version: 4
Effective Time: 20231110
 
Sato Pharmaceutical Co., Ltd.